TUR is both diagnostic and therapeutic, and findings or outcomes can dictate further disease management. Restaging TUR in patients with T1 tumors is an important component of management. Intravesical ...

Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery Approximately 30% to 40% patients with a superficial ...

Bladder cancer is a heterogeneous disease. Non–muscle-invasive bladder cancer embraces a spectrum of tumors with varying degrees of clinical behavior. Transurethral resection remains the surgical ...

You've been diagnosed with bladder cancer that has not invaded the muscle layer -- i.e., non-muscle invasive bladder cancer (NMIBC), also called superficial bladder cancer. Although the cure rate with ...

The treatment of bladder cancer could see a major advancement thanks to an innovative drug delivery approach. This targeted method specifically attacks tumors resistant to conventional ...

In this segment of Case-by-Case, Dr Petros Grivas applies NIAGARA data to a bladder cancer case, examining the role of ctDNA in perioperative decisions.

SAN FRANCISCO—Intravesical gemcitabine may be a safe and effective treatment for superficial bladder cancer, data suggest. Australian investigators tested the treatment in a Phase II trial that ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

Small cell bladder cancer is a rare type of bladder cancer. It’s more aggressive than other types of bladder cancer and those with it have a poorer outlook. Treatment can involve surgery, chemotherapy ...

Symptoms of bladder cancer can include issues that relate to passing urine, such as blood in urine and changes in the frequency of urination. Overall, bladder cancer is more common in males than in ...

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...